BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8165703)

  • 21. Erythrocytosis after renal transplant: study of erythroid progenitors and response to enalapril.
    Rostaing L; Demur C; Huyn A; Durand D; Lloveras JJ; Suc JM
    Transplant Proc; 1994 Feb; 26(1):280-1. PubMed ID: 8108980
    [No Abstract]   [Full Text] [Related]  

  • 22. Ramipril in post-renal transplant erythrocytosis.
    Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
    J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized placebo-controlled study of enalapril in the treatment of erythrocytosis after renal transplantation.
    Beckingham IJ; Woodrow G; Hinwood M; Rigg KM; Morgan AG; Burden RP; Broughton-Pipkin F
    Nephrol Dial Transplant; 1995 Dec; 10(12):2316-20. PubMed ID: 8808232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term effects of ACE inhibitors on the erythrocytosis in renal transplant recipients.
    Lal SM; Trivedi HS; Ross G
    Int J Artif Organs; 1995 Jan; 18(1):13-6. PubMed ID: 7607751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of aminophylline and enalapril in posttransplant polycythemia.
    Mazzali M; Filho GA
    Transplantation; 1998 Jun; 65(11):1461-4. PubMed ID: 9645803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
    Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
    Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of post-transplant erythrocytosis by enalapril.
    Wong KC; Bandler NS; Kerr PG; Atkins RC
    Med J Aust; 1994 Nov; 161(9):544-6. PubMed ID: 7968756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
    Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
    Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive effect of enalapril on erythrocytosis after renal transplantation.
    Rhee SR; Park SK; Kang SK; Kim SH; Cho BH; Kim JH
    Transplant Proc; 1996 Jun; 28(3):1555-6. PubMed ID: 8658783
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors inducing posttransplant erythrocytosis.
    Lezaić V; Djukanović LJ; Pavlović-Kentera V; Clemons G; Biljanović-Paunović L
    Eur J Med Res; 1997 Sep; 2(9):407-12. PubMed ID: 9300939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
    Ersoy A; Kahvecioglu S; Ersoy C; Cift A; Dilek K
    Transplant Proc; 2005 Jun; 37(5):2148-50. PubMed ID: 15964363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
    Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
    Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis.
    Kiykim AA; Genctoy G; Horoz M; Tiftik NE; Gok E; Altun B; Arici M; Haznedaroglu I
    Artif Organs; 2009 Dec; 33(12):1086-90. PubMed ID: 19958348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
    Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
    Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin production after kidney transplantation.
    Gaciong Z; Koziak K; Jarzyło I; Ludwicki K; Malanowska S; Paczek L; Szmidt J; Wałaszewski J; Lao M
    Ann Transplant; 1996; 1(1):29-33. PubMed ID: 9869934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
    Hernández E; Morales JM; Andrés A; Ortuño B; Praga M; Alcazar JM; Fernández G; Rodicio JL
    Transplant Proc; 1995 Aug; 27(4):2239-41. PubMed ID: 7652789
    [No Abstract]   [Full Text] [Related]  

  • 37. Ketanserin: a new perspective in posttransplant erythrocytosis?
    Borawski J; Mazerska M; Rydzewski A; Pawlak K; Rowinski M; Mysliwiec M
    Clin Transplant; 1996 Feb; 10(1 Pt 1):63-6. PubMed ID: 8652901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].
    Duclos J
    Rev Med Chil; 2000 Feb; 128(2):211-2. PubMed ID: 10962891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hematologic findings and value of value of endogenous creatinine in patients following kidney transplantation].
    Zadrazil J; Bachleda P; Krejcí K
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():103-6. PubMed ID: 10743736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron deficiency--an underrecognized problem in nonanemic and erythrocytic kidney transplant recipients: risks and effects of ACEI and of iron treatment.
    Jimeno L; Rodado R; Campos M; Lanuza M
    Transplant Proc; 2005 Mar; 37(2):1007-8. PubMed ID: 15848606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.